Michael Jung
Founder at Enlibrium, Inc.
Profile
Michael Jung is the founder of Aragon Pharmaceuticals, Inc. (founded in 2009) and Seragon Pharmaceuticals, Inc. (founded in 2013).
He is also the founder of Enlibrium, Inc. Dr. Jung's current job is as a Professor at the University of California, Berkeley.
Michael Jung active positions
Companies | Position | Start |
---|---|---|
University of California, Berkeley | Corporate Officer/Principal | 07/04/2010 |
Enlibrium, Inc.
Enlibrium, Inc. Medical/Nursing ServicesHealth Services Enlibrium, Inc. provides medical services. It develops novel drugs based on the anti-cancer activity of metformin and designed to reduce cancer energy production to treat a range of cancer types. The company was founded by Michael Jung and Richard Pietras and is headquartered in La Jolla, CA. | Founder | - |
Former positions of Michael Jung
Companies | Position | End |
---|---|---|
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Founder | - |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Health Technology |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Health Technology |
Enlibrium, Inc.
Enlibrium, Inc. Medical/Nursing ServicesHealth Services Enlibrium, Inc. provides medical services. It develops novel drugs based on the anti-cancer activity of metformin and designed to reduce cancer energy production to treat a range of cancer types. The company was founded by Michael Jung and Richard Pietras and is headquartered in La Jolla, CA. | Health Services |
- Stock Market
- Insiders
- Michael Jung